Tustumi<sup>1 F, a</sup> , Albenda<sup>2 DG, b</sup> , Sallum<sup>1 RAA, c</sup> , et al. <sup>18</sup>F-FDG-PET/CT-measured parameters as potential predictors of residual disease after neoadjuvant chemoradiotherapy in patients with esophageal carcinoma. Radiol Bras 2022;55:286-292